Liver X Receptor Regulates Arachidonic Acid Distribution and Eicosanoid Release in Human Macrophages: A Key Role for Lysophosphatidylcholine Acyltransferase 3

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.112.300812PMID 23580142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abstract 130: Lysophosphatidylcholine Acyltransferase 3 Knockdown-Mediated Liver Lysophosphatidylcholine Accumulation Promotes Very-Low-Density Lipoprotein Production by Enhancing Microsomal Triglyceride Transfer Protein Expression

  2012cited by this paper
• Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1

  2012cited by this paper
• Lysophosphatidylcholine Acyltransferase 3 Knockdown-mediated Liver Lysophosphatidylcholine Accumulation Promotes Very Low Density Lipoprotein Production by Enhancing Microsomal Triglyceride Transfer Protein Expression*

  2012cited by this paper
• Regulation of LPCAT3 by LXR.

  2011cited by this paper
• Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells

  2011influential reference
• Activation of Liver X Receptor Sensitizes Human Dendritic Cells to Inflammatory Stimuli

  2010cited by this paper
• Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance.

  2010influential reference
• Characterization of human lysophospholipid acyltransferase 3[S]

  2009cited by this paper
• Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.

  2009cited by this paper
• Signaling Role for Lysophosphatidylcholine Acyltransferase 3 in Receptor-Regulated Arachidonic Acid Reacylation Reactions in Human Monocytes

  2009cited by this paper
• Peroxisome proliferators attenuate free arachidonic acid pool in the kidney through inducing lysophospholipid acyltransferases.

  2009cited by this paper
• Acyl-CoA:Lysophospholipid Acyltransferases*

  2009cited by this paper
• Liver X Receptor Agonists Inhibit the Phospholipid Regulatory Gene CTP: Phosphoethanolamine Cytidylyltransferase-Pcyt2

  2008cited by this paper
• Integration of metabolism and inflammation by lipid-activated nuclear receptors

  2008influential reference
• Substrate Preferences of a Lysophosphatidylcholine Acyltransferase Highlight Its Role in Phospholipid Remodeling

  2008cited by this paper
• Lysophospholipid metabolism facilitates Toll‐like receptor 4 membrane translocation to regulate the inflammatory response

  2008cited by this paper
• Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity

  2008cited by this paper
• Regulation of Macrophage Functions by PPAR-&agr;, PPAR-&ggr;, and LXRs in Mice and Men

  2008cited by this paper
• Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery.

  2008cited by this paper
• Identification and Characterization of a Major Liver Lysophosphatidylcholine Acyltransferase*

  2008cited by this paper
• Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

  2007influential reference
• Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages

  2007influential reference
• Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis

  2006cited by this paper
• Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

  2004cited by this paper
• Suppression of Macrophage Eicosanoid Synthesis by Atherogenic Lipoproteins Is Profoundly Affected by Cholesterol-Fatty Acyl Esterification and the Niemann-Pick C Pathway of Lipid Trafficking*

  2004cited by this paper
• Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice

  2004cited by this paper
• Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

  2003cited by this paper
• Polyunsaturated Fatty Acids Suppress Sterol Regulatory Element-binding Protein 1c Promoter Activity by Inhibition of Liver X Receptor (LXR) Binding to LXR Response Elements*

  2002cited by this paper
• Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans.

  2001cited by this paper
• Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR

  2001cited by this paper
• Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men

  1998cited by this paper
• Control of arachidonate levels within inflammatory cells.

  1996cited by this paper
• Decreased arachidonate metabolism in mouse peritoneal macrophages after foam cell transformation with oxidized low-density lipoproteins.

  1992cited by this paper
• Rapid separation of lipid classes in high yield and purity using bonded phase columns.

  1985cited by this paper
• Selective incorporation of polyunsaturated fatty acids into phosphatidylcholine by rat liver microsomes.

  1982cited by this paper
• Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis.

  1958cited by this paper
• The function of cytidine coenzymes in the biosynthesis of phospholipides.

  1956cited by this paper

• Immunometabolic programming of macrophages in asthma pathogenesis and therapy

  2026cites this paper
• LPCAT3—dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis

  2025cites this paper
• Plasmalogen remodeling modulates macrophage response to cytotoxic oxysterols and atherosclerotic plaque vulnerability

  2025cites this paper
• Laminar shear stress promotes accumulation of polyunsaturated fatty acid in aortic endothelial cells through upregulation of LPCAT3 enzyme activity.

  2025cites this paper
• LPCAT3-ABCA1 axis regulates the dose-sparing effects of steroid drugs in osteoarthritis in mice.

  2025cites this paper
• Research progress, challenges and perspectives of phospholipids metabolism in the LXR-LPCAT3 signaling pathway and its relation to NAFLD (Review)

  2024cites this paper
• Fatty acid abnormalities in cystic fibrosis–the missing link for a cure?

  2024cites this paper
• Liver X receptor agonist upregulates LPCAT3 in human aortic endothelial cells.

  2024cites this paper
• Integrated multi-omics analyses reveal the altered transcriptomic characteristics of pulmonary macrophages in immunocompromised hosts with Pneumocystis pneumonia

  2023cites this paper
• Inhibiting phosphatidylcholine remodeling in adipose tissue increases insulin sensitivity.

  2023cites this paper
• The role of lipid metabolic reprogramming in tumor microenvironment

  2023cites this paper
• LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages

  2022cites this paper
• The Patatin–Like Phospholipase Domain Containing Protein 7 Regulates Macrophage Classical Activation through SIRT1/NF-κB and p38 MAPK Pathways

  2022cites this paper
• Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation

  2022cites this paper
• Liver X receptor: a potential target in the treatment of atherosclerosis

  2022cites this paper
• Lysophosphatidylcholine acyltransferase 3 (LPCAT3) mediates palmitate-induced inflammation in macrophages of large yellow croaker (Larimichthys crocea).

  2022cites this paper
• The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease

  2022cites this paper
• Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?

  2021cites this paper
• Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma

  2021cites this paper
• Liver X receptors conserve the therapeutic target potential for the treatment of Rheumatoid arthritis.

  2021cites this paper
• LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function

  2021cites this paper
• Metabolomics Insights into Oleate-Induced Disorders of Phospholipid Metabolism in Macrophages.

  2021cites this paper
• Lipid metabolism in asthma: Immune regulation and potential therapeutic target.

  2021cites this paper
• Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development.

  2021cites this paper
• Liver X receptors and liver physiology.

  2021cites this paper
• The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3

  2021cites this paper
• Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection

  2021cites this paper
• Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet

  2020cites this paper
• Deletion of lysophosphatidylcholine acyltransferase3 in myeloid cells worsens hepatic steatosis after a high fat diet.

  2020cites this paper
• Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development.

  2020cites this paper
• Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation

  2020cites this paper
• Inflammation Triggers Liver X Receptor-Dependent Lipogenesis

  2019cites this paper
• Phospholipid Remodeling in Physiology and Disease.

  2019cites this paper
• Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model

  2019cites this paper
• A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity

  2019cites this paper
• Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis

  2019cites this paper
• Activation of the liver X receptors alters CD4+ T cell membrane lipids and signalling through direct regulation of glycosphingolipid synthesis

  2019cites this paper
• Liver X Receptors and Male (In)fertility

  2019cites this paper
• Macrophage fatty acid metabolism and atherosclerosis: The rise of PUFAs.

  2019cites this paper
• Lipid Homeostasis on Cell Membrane

  2019cites this paper
• LXR alters CD4+ T cell function through direct regulation of glycosphingolipid synthesis

  2019cites this paper
• LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.

  2018cites this paper
• Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.

  2018cites this paper
• Recent progress of lysophosphatidylcholine acyltransferases in metabolic disease and cancer

  2018cites this paper
• The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease

  2018cites this paper
• Liver X receptors in lipid signalling and membrane homeostasis

  2018cites this paper
• Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression

  2017cites this paper
• Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways

  2017cites this paper
• Essential Role for Ethanolamine Plasmalogen Hydrolysis in Bacterial Lipopolysaccharide Priming of Macrophages for Enhanced Arachidonic Acid Release

  2017cites this paper
• Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases.

  2017cites this paper
• Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ*

  2016cites this paper
• The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response.

  2016cites this paper
• Fatty acid metabolism in macrophages: a target in cardio-metabolic diseases

  2016cites this paper
• Lysophosphatidylethanolamine acyltransferase 1/membrane‐bound O‐acyltransferase 1 regulates morphology and function of P19C6 cell‐derived neurons

  2016cites this paper
• Cholesterol‐sensing liver X receptors stimulate Th2‐driven allergic eosinophilic asthma in mice

  2016cites this paper
• Polyunsaturated fatty acid–phospholipid remodeling and inflammation

  2015cites this paper
• Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation*

  2015cites this paper
• Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA‐Treated U937 Cells

  2015influential citation
• Liver X receptors at the intersection of lipid metabolism and atherogenesis.

  2015cites this paper
• Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.

  2015cites this paper
• Liver X Receptor Activation Promotes Polyunsaturated Fatty Acid Synthesis in Macrophages: Relevance in the Context of Atherosclerosis

  2015cites this paper
• Liver X receptors in immune cell function in humans.

  2015cites this paper
• Recent Highlights of ATVB

  2014cites this paper
• Macrophages

  2014cites this paper
• Characterization Of Human Lysophospholipid Acyltransferases In The Regulation Of Membrane Trafficking

  2014cites this paper
• Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells

  2014cites this paper
• Liver X Receptor Activation Stimulates Iron Export in Human Alternative Macrophages

  2013cites this paper
• LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.

  2013cites this paper